Ascendis to Share Its Latest Endocrinology Rare Disease
COPENHAGEN, Denmark, May 05, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will share the latest...
COPENHAGEN, Denmark, May 05, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will share the latest...
There are about 500 new cases of the disease in humans per year in the US, according to the Creutzfeldt-Jakob...
Newswise — ANN ARBOR, Mich. – A new clinical trial will allow researchers to study 3D-printed bioresorbable devices aimed at...